Aurdan Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Aurdan Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,172	Closed	-$576K	–	103
2026 Q1	$576K	Sell	1,172 -218	-16%	-$118K	0.17%	63
2025 Q4	$805K	Sell	1,390 -214	-13%	-$121K	0.25%	50
2025 Q3	$778K	Sell	1,604 -3,285	-67%	-$1.53M	0.25%	49
2025 Q2	$1.98M	Sell	4,889 -976	-17%	-$408K	0.68%	37
2025 Q1	$2.92M	Sell	5,865 -3,178	-35%	-$1.72M	1.1%	24
2024 Q4	$4.7M	Buy	+9,043	New	+$4.97M	1.81%	18

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Aurdan Capital Management's TMO Position: Q2 2026 in Review

Aurdan Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 1,172 shares — an estimated $576K sold.

Aurdan Capital Management first reported a position in TMO in Q4 2024 and held it in 6 quarters. The position peaked at $4.7M in Q4 2024. 1,179 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Aurdan Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Aurdan Capital Management sold 1,172 Thermo Fisher Scientific shares in Q2 2026, an estimated $576K.
Aurdan Capital Management first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 6 quarters.
Aurdan Capital Management's Thermo Fisher Scientific position peaked at $4.7M in Q4 2024.
1,179 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Aurdan Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.